SLC2A1 and cancer: Several meta-analyses also show GLUT1 is an adverse prognostic factor in several cancers: lung (n=1,423 (87) and n=1,665 (88)), BCa (n=1,861) (89), colorectal cancer [CRC] (n=2,077) (90), and OSCC (n=1,301) (91).